Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

10.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

3.4K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

8.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

39.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

9.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt.

Science advances·2026
Same author

A deep learning-based computational pipeline predicts developmental outcome in retinal organoids.

PLoS biology·2026
Same author

Establishing an auxin-inducible GFP nanobody-based acute protein knockdown system to mimic hypomorphic mutations during early medaka embryogenesis.

Biology open·2025
Same author

Discovery and characterisation of gene by environment and epistatic genetic effects in a vertebrate model.

bioRxiv : the preprint server for biology·2025
Same author

Natural genetic variation quantitatively regulates heart rate and dimension.

Nature communications·2025
Same author

Vaginal drainage of semen in underwear: A forensic study.

Science & justice : journal of the Forensic Science Society·2024

Related Experiment Video

Updated: Apr 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K

TRIM25 has a dual function in the p53/Mdm2 circuit.

P Zhang1,2, S Elabd1, S Hammer3

  • 1Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.

Oncogene
|March 3, 2015
PubMed
Summary
This summary is machine-generated.

TRIM25 is a novel regulator of the tumor suppressor p53 and its inhibitor Mdm2. TRIM25 increases p53 and Mdm2 levels but inhibits p53 activity, impacting cell death and DNA damage response.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

346

Related Experiment Videos

Last Updated: Apr 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

346

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The p53 protein is a critical tumor suppressor that halts cell growth and induces cell death.
  • Mdm2 protein inhibits p53, targeting it for degradation, which is crucial for controlling p53 levels.

Purpose of the Study:

  • To identify novel regulators of p53 and Mdm2.
  • To elucidate the mechanism by which TRIM25 affects p53 and Mdm2.

Main Methods:

  • Genetic screening to identify TRIM25 as a regulator.
  • Co-precipitation assays to study protein interactions.
  • Analysis of ubiquitination and degradation pathways.
  • Cell death assays in HCT116 cells.
  • Embryogenesis studies in medaka.

Main Results:

  • TRIM25 was identified as a novel regulator of p53 and Mdm2.
  • TRIM25 increases p53 and Mdm2 protein levels by inhibiting their ubiquitination and proteasomal degradation.
  • TRIM25 interferes with p300 and Mdm2 association, a key step for p53 polyubiquitination.
  • TRIM25 inhibits p53 activity, leading to reduced p53-dependent cell death and DNA damage response.
  • TRIM25 downregulation causes apoptosis during medaka embryogenesis, which is rescued by p53 downregulation.

Conclusions:

  • TRIM25 is a novel negative regulator of p53 tumor suppressor activity.
  • TRIM25 plays a significant role in controlling cell death and DNA damage response pathways.
  • TRIM25's regulation of p53 is functionally relevant in an organismal context, impacting embryonic development.